Travere Therapeutics (TVTX) FY Conference August 13, 2025 08:00 AM ET Speaker0Hi. Good morning, everyone, and thank you for joining us. My name is Edward Nash, senior biotechnology analyst on the equity research team at Canaccord Genuity. I have the pleasure of having with us today, Trevere Therapeutics. With us from Trevere, I have Chris Klein, who's the chief financial officer.Thank you very much, Chris, for joining us. Thank you for having us. So maybe as we to start off, if you could maybe just give us ...